PAPPA and preeclampsia: Prior research on clinical prediction models for preeclampsia has primarily focused on high-resource environments, where first-trimester biomarker screening using placental growth factor, pregnancy-associated plasma protein A, and specialized ultrasound assessments can achieve AUROCs of 0.75–0.90 for early-onset preeclampsia [8,21].